TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 245 filers reported holding TANDEM DIABETES CARE INC in Q2 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $295,781 | -81.0% | 12,053 | -68.6% | 0.00% | -83.3% |
| Q1 2023 | $1,560,439 | +39565.5% | 38,425 | -56.1% | 0.01% | -57.1% |
| Q4 2022 | $3,934 | -100.0% | 87,512 | -69.8% | 0.01% | -73.6% |
| Q3 2022 | $13,887,000 | -33.7% | 290,215 | -18.0% | 0.05% | -32.1% |
| Q2 2022 | $20,960,000 | +50.2% | 354,109 | +195.2% | 0.08% | +100.0% |
| Q1 2022 | $13,952,000 | +52.5% | 119,974 | +97.4% | 0.04% | +44.4% |
| Q4 2021 | $9,148,000 | +71.7% | 60,776 | +36.2% | 0.03% | +58.8% |
| Q3 2021 | $5,329,000 | -86.3% | 44,636 | -88.8% | 0.02% | -87.1% |
| Q2 2021 | $38,936,000 | +116.0% | 399,752 | +95.7% | 0.13% | +80.8% |
| Q1 2021 | $18,027,000 | +5586.8% | 204,271 | +6069.5% | 0.07% | +7200.0% |
| Q4 2020 | $317,000 | -78.5% | 3,311 | -74.5% | 0.00% | -87.5% |
| Q3 2020 | $1,472,000 | +46.9% | 12,972 | -22.9% | 0.01% | +33.3% |
| Q4 2019 | $1,002,000 | – | 16,814 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,022,257 | $60,293,000 | 5.97% |
| APIS CAPITAL ADVISORS, LLC | 50,000 | $2,949,000 | 4.62% |
| SECTORAL ASSET MANAGEMENT INC | 432,815 | $25,527,000 | 4.40% |
| CROWN ADVISORS MANAGEMENT, INC. | 75,000 | $4,424,000 | 2.96% |
| OBERWEIS ASSET MANAGEMENT INC/ | 199,410 | $11,761,000 | 2.66% |
| Asymmetry Capital Management, L.P. | 18,995 | $1,120,000 | 2.40% |
| Redmile Group, LLC | 1,160,401 | $68,440,000 | 2.29% |
| FRIESS ASSOCIATES LLC | 501,985 | $29,607,000 | 2.29% |
| Atika Capital Management LLC | 142,000 | $8,375,000 | 1.76% |
| Chicago Capital, LLC | 433,083 | $25,543,000 | 1.71% |